Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone sodium-sulbactam sodium for uncomplicated gonorrhea
CTR20150481Phase 4Active
- Sponsor
- Xiangbei Welman Pharmaceuticals
- Start
- Jul 2015
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone + sulbactam in gonorrhea, sponsored by Xiangbei Welman Pharmaceuticals. Started Jul 2015; status: active.
02
Drugs
ceftriaxone + sulbactam
03
Conditions
gonorrhea
Beyond the preview
Go deeper on CTR20150481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150481.